Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2003 | 12-2002 | 12-2001 | |
| Sales | 0 | 0 | 2,359 |
| Gross Profit | N/A | N/A | 2,359 |
| Operating Expenses | 4,849 | 0 | 21,890 |
| Operating Income | -4,849 | N/A | -19,531 |
| Other Income | 131 | 0 | 1,119 |
| Pre-tax Income | -4,718 | 0 | -18,412 |
| Net Income Continuous | -4,718 | N/A | -18,412 |
| Net Income | $-4,718 | $N/A | $-18,412 |
| EPS Basic Total Ops | -26.80 | N/A | -122.90 |
| EPS Basic Continuous Ops | -26.82 | N/A | -122.91 |
| EPS Diluted Total Ops | -26.80 | N/A | -122.90 |
| EPS Diluted Continuous Ops | -26.82 | N/A | -122.91 |
| EBITDA(a) | $-4,496 | $N/A | $-18,895 |